I actually didn't see this part when I read it the first time, LOL
Ok, let's see:
No money in vaccines? (I really got into this during the bogus swine flu scare, so bookmarked dates are older - just Google "Vaccine Profits")
With the $780 billion global prescription drug market growing at a sluggish 5% a year, many analysts reckon that the vaccine industry, which is forecast to climb 13% annually through 2012, offers the most upside potential. "More companies are investing in vaccines as a way of diversifying away from prescription drugs, and new technologies such as cell culture are enabling them to produce more sophisticated vaccines," says Michael Boyd, acting director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). Flu Vaccine Spurs Pharma DealsWitness the slew of recent dealmaking centered on vaccines. Through its $68 billion acquisition of Wyeth, Pfizer is now in the vaccine business. On Sept. 28, Abbott Laboratories (ABT) splashed out $6.6 billion for Belgian flu vaccine maker Solvay, while Johnson & Johnson (JNJ) bought 18% of Dutch vaccine manufacturer Crucell (CRXL). GSK—which looks set to enjoy a windfall from swine flu vaccine—also recently inked a $2.2 billion 10-year deal to provide Brazil with its pneumococcal vaccine. As emerging economies mature and health-care spending rises there, vaccines also offer drug companies attractive new markets. In June, GSK signed a $78 million joint venture with China's Shenzhen Neptunus Interlong Bio-Technique to develop flu vaccines. A month later, Sanofi acquired a majority stake in Indian vaccine maker Shantha Biotechnics, valuing the company at $824 million. And on Nov. 4, Novartis spent $125 million for an 85% stake in privately owned Chinese vaccines company Zhejiang Tianyuan. A Seasonal Shot in the ArmIn the short term, at least, H1N1 vaccine sales will give a major lift to sales at the three major European vaccine makers. GSK says analyst predictions for $1.7 billion of H1N1 vaccine sales in the fourth quarter are broadly accurate, and similar numbers are forecast for the first quarter 2010. Novartis says it expects $700 million in fourth-quarter sales alone of its H1N1 pandemic vaccine.
Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.
"The vaccine market is booming," says Bruce Carlson, spokesperson at market research firm Kalorama, which publishes an annual survey of the vaccine industry. "It's an enormous growth area for pharmaceuticals at a time when other areas are not doing so well," he says, noting that the pipeline for more traditional blockbuster drugs such as Lipitor and Nexium has thinned.
As always with pandemic flus, taxpayers are footing the $1.5 billion check for the 250 million swine flu vaccines that the government has ordered so far and will be distributing free to doctors, pharmacies and schools. In addition, Congress has set aside more than $10 billion this year to research flu viruses, monitor H1N1's progress and educate the public about prevention.
Drugmakers pocket most of the revenues from flu sales, with Sanofi-Pasteur, Glaxo Smith Kline and Novartis cornering most of the market.
So, yes, they do make money - Pfizer et. al. get paid for every dose made.
US Population = 322,000,000
Yearly deaths from Rotavirus = 20-60
I can totally see how there is no profit in this vaccine, especially for the Dr that helped create it being on the CDC ACIP and voting for it to be added. Estimates on his take home when the royalties were sold are around $46,000,000.
Projected 2015 HPV infections = 12,000 Projected deaths = 4,000 (Remember we have 322 Million residents, somebody type up a percentage)
I can totally see how there is no money to be made by having every person (the dream scenario) in the US vaccinated (even men for God's sake) for HPV.
Hepatitus B. One of the 36 needles they want to stick kids with. Unless you are in AFRICA, there is about a 0.5% chance you will contract Hep B.
Which, by the way, is *primarily* contracted through sexual acts. Yep, those infants "in their first day of life" really need that one.
There's no shot for AIDS, yet we don't have millions of poor little kiddies dying in hospitals... because like AIDS, kids (and people) just don't die from a large majority of the "diseases" they want to inoculate them for. Chicken Pox? Oh, the thing that made me itch and miss school for a couple of days? Good God how did we survive Chicken Pox without a vaccine. Everybody Ok? Nobody caught Ebola? Ok, good.
You can't make money off of most of the illnesses these shots are for... because the rates of infection are minuscule on a national scale. But you *can* make money by inoculating as many as possible for those very diseases.
However, I'll take odds that you will NEVER see a cure for Diabetes or Cancer, LOL
Or, believe what you are told, because large corporations have zero effect on your daily lives, what 2008 financial crisis?
If I had a kid tomorrow, they would get vaccinated. Would they get 36 of them? Heck no.